We've found
10,842 Neurology
clinical trials
Neurology, Psychiatry / Psychology Clinical Trial
Improving the Recovery and Outcome Every Day After the ICU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Improving the Recovery and Outcome Every Day After the ICU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Improving the Recovery and Outcome Every Day After the ICU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Interventions for Parent Caregivers of Injured Military/Veteran Personnel
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Assessment of Pharmacokinetics and Safety of Diazepam Buccal Soluble Film in Pediatric Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Sleep/Wake Protocol Implementation to Improve Sleep Quality in the ICU
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Stroke Clinical Trial
Improving Measurement and Treatment of Post-stroke Neglect
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Stroke Recovery Initiative - Registry for Stroke Research Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Brain Injuries Clinical Trial
Language Assessment and Treatment Following Acquired Brain Injury
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Role of Metformin on Muscle Health of Older Adults
Status: Enrolling,
Phase
Updated: 3/13/2018
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease; Dementia Clinical Trial
APOE Genotype and Diet Influences on Alzheimer's Biomarkers
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Primary Mitochondrial Myopathy Clinical Trial
A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Extension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Mitochondrial Myopathy Clinical Trial
A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Extension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Noninvasive Brain Stimulation for Mild Cognitive Impairment
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Musculoskeletal, Neurology, Rheumatology Clinical Trial
Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal, Neurology, Rheumatology Clinical Trial
Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Frontotemporal Dementia Clinical Trial
Intranasal Oxytocin for Frontotemporal Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
10,842 Neurology
clinical trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Improving the Recovery and Outcome Every Day After the ICU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Improving the Recovery and Outcome Every Day After the ICU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Improving the Recovery and Outcome Every Day After the ICU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Updated: 12/31/1969
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Updated: 12/31/1969
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Updated: 12/31/1969
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Updated: 12/31/1969
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Updated: 12/31/1969
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Interventions for Parent Caregivers of Injured Military/Veteran Personnel
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
AMPLATZER PFO Occluder Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Assessment of Pharmacokinetics and Safety of Diazepam Buccal Soluble Film in Pediatric Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Dementia Clinical Trial
Updated: 12/31/1969
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 10/20/2017
Sleep/Wake Protocol Implementation to Improve Sleep Quality in the ICU
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
Improving Measurement and Treatment of Post-stroke Neglect
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/31/1969
Stroke Recovery Initiative - Registry for Stroke Research Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Brain Injuries Clinical Trial
Updated: 12/31/1969
Language Assessment and Treatment Following Acquired Brain Injury
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Updated: 3/13/2018
Role of Metformin on Muscle Health of Older Adults
Status: Enrolling,
Phase
Updated: 3/13/2018
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease; Dementia Clinical Trial
Updated: 10/25/2017
APOE Genotype and Diet Influences on Alzheimer's Biomarkers
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Primary Mitochondrial Myopathy Clinical Trial
Updated: 12/31/1969
A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Extension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Mitochondrial Myopathy Clinical Trial
Updated: 12/31/1969
A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Extension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Updated: 12/31/1969
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Updated: 12/31/1969
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Updated: 12/31/1969
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Updated: 12/31/1969
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dementia-related Psychosis Clinical Trial
Updated: 12/31/1969
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 4/3/2018
Noninvasive Brain Stimulation for Mild Cognitive Impairment
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Musculoskeletal, Neurology, Rheumatology Clinical Trial
Updated: 12/31/1969
Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal, Neurology, Rheumatology Clinical Trial
Updated: 12/31/1969
Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Updated: 12/31/1969
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Updated: 12/31/1969
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Updated: 12/31/1969
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Updated: 12/31/1969
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Updated: 12/31/1969
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Frontotemporal Dementia Clinical Trial
Updated: 12/31/1969
Intranasal Oxytocin for Frontotemporal Dementia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials